| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:2004.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic
From the Department of Pharmacology, K.U.L., Leuven, Belgium (L.M.H.), and AstraZeneca, Research & Development, Mölndal, Sweden (L.C., G.D.).
Correspondence to Luc M. Hondeghem, MD, PhD, H.P.C. nv, Westlaan 85, B-8400 Oostende, Belgium. E-mail luchondeghem{at}yahoo.com
Background—Prolongation of action potential duration (APD) is considered a major antiarrhythmic mechanism (class 2I), but paradoxically, it frequently is also proarrhythmic (torsade de pointes).
Methods and Results—The cardiac electrophysiological effects of 702 chemicals (class 2I or HERG channel block) were studied in 1071 rabbit Langendorff-perfused hearts. Temporal instability of APD, triangulation (duration of phase 3 repolarization), reverse use-dependence, and induction of ectopic beats were measured. Instability, triangulation, and reverse use-dependence were found to be important determinants of proarrhythmia. Agents that lengthened the APD by >50 ms, with induction of instability, triangulation, and reverse use-dependence (n=59), induced proarrhythmia (primarily polymorphic ventricular tachycardia); in their absence (n=19), the same prolongation of APD induced no proarrhythmia but significant antiarrhythmia (P<0.001). Shortening of APD, when accompanied by instability and triangulation, was also markedly proarrhythmic (primarily monomorphic ventricular tachycardia). In experiments in which instability and triangulation were present, proarrhythmia declined with prolongation of APD, but this effect was not large enough to become antiarrhythmic. Only with agents without instability did prolongation of APD become antiarrhythmic. For 20 selected compounds, it was shown that instability of APD and triangulation observed in vitro were strong predictors of in vivo proarrhythmia (torsade de pointes).
Conclusions—Lengthening of APD without instability or triangulation is not proarrhythmic but rather antiarrhythmic.
Key Words: antiarrhythmia agents • torsade de pointes • arrhythmia • drugs • action potentials
This article has been cited by other articles:
 |
|
 |
|
  L. Romero, E. Pueyo, M. Fink, and B. Rodriguez Impact of ionic current variability on human ventricular cellular electrophysiology Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1436 - H1445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pueyo, J. P. Martinez, and P. Laguna Cardiac repolarization analysis using the surface electrocardiogram Phil Trans R Soc A, January 28, 2009; 367(1887): 213 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Couderc, S. Kaab, M. Hinterseer, S. McNitt, X. Xia, A. Fossa, B. M. Beckmann, S. Polonsky, and W. Zareba Baseline Values and Sotalol-Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug-Induced Torsades de Pointes J. Clin. Pharmacol., January 1, 2009; 49(1): 6 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Dujardin, B. Dumotier, M. David, M. Guizy, C. Valenzuela, and L. M. Hondeghem Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1414 - H1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hinterseer, M. B. Thomsen, B.-M. Beckmann, A. Pfeufer, R. Schimpf, H.-E. Wichmann, G. Steinbeck, M. A. Vos, and S. Kaab Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study Eur. Heart J., January 2, 2008; 29(2): 185 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Thomsen, A. Oros, M. Schoenmakers, J. M. van Opstal, J. N. Maas, J. D.M. Beekman, and M. A. Vos Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation Cardiovasc Res, February 1, 2007; 73(3): 521 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Thomsen, P. G.A. Volders, J. D.M. Beekman, J. Matz, and M. A. Vos Beat-to-Beat Variability of Repolarization Determines Proarrhythmic Outcome in Dogs Susceptible to Drug-Induced Torsades de Pointes J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1268 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wisialowski, K. Crimin, J. Engtrakul, J. O'Donnell, B. Fermini, and A. A. Fossa Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 352 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Fossa, T. Wisialowski, and K. Crimin QT Prolongation Modifies Dynamic Restitution and Hysteresis of the Beat-to-Beat QT-TQ Interval Relationship during Normal Sinus Rhythm under Varying States of Repolarization J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu, J. C. Shryock, Y. Song, and L. Belardinelli An Increase in Late Sodium Current Potentiates the Proarrhythmic Activities of Low-Risk QT-Prolonging Drugs in Female Rabbit Hearts J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 718 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Kowey and G.-X. Yan Making a Silk Purse Out of a Sow's Ear J. Am. Coll. Cardiol., August 16, 2005; 46(4): 688 - 689. [Full Text] [PDF]
|
|
|
|
|
|
P. Milberg, N. Reinsch, K. Wasmer, G. Monnig, J. Stypmann, N. Osada, G. Breithardt, W. Haverkamp, and L. Eckardt Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3 Cardiovasc Res, February 1, 2005; 65(2): 397 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Thomsen, S. C. Verduyn, M. Stengl, J. D.M. Beekman, G. de Pater, J. van Opstal, P. G.A. Volders, and M. A. Vos Increased Short-Term Variability of Repolarization Predicts d-Sotalol-Induced Torsades de Pointes in Dogs Circulation, October 19, 2004; 110(16): 2453 - 2459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu, J. C. Shryock, Y. Song, Y. Li, C. Antzelevitch, and L. Belardinelli Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J Curtis Is cardiac IKs a relevant drug target? Cardiovasc Res, March 1, 2004; 61(4): 651 - 652. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Sanguinetti and P. B. Bennett Antiarrhythmic Drug Target Choices and Screening Circ. Res., September 19, 2003; 93(6): 491 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G.A. Volders, M. Stengl, J. M. van Opstal, U. Gerlach, R. L.H.M.G. Spatjens, J. D.M. Beekman, K. R. Sipido, and M. A. Vos Probing the Contribution of IKs to Canine Ventricular Repolarization: Key Role for {beta}-Adrenergic Receptor Stimulation Circulation, June 3, 2003; 107(21): 2753 - 2760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Redfern, L. Carlsson, A.S. Davis, W.G. Lynch, I. MacKenzie, S. Palethorpe, P.K.S. Siegl, I. Strang, A.T. Sullivan, R. Wallis, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development Cardiovasc Res, April 1, 2003; 58(1): 32 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nemec, J. B. Hejlik, W.-K. Shen, and M. J. Ackerman Catecholamine-Induced T-Wave Lability in Congenital Long QT Syndrome: A Novel Phenomenon Associated With Syncope and Cardiac Arrest Mayo Clin. Proc., January 1, 2003; 78(1): 40 - 50. [Abstract] [PDF]
|
|
|
|
|
|
C.F. Starmer, T. J. Colatsky, and A. O. Grant What happens when cardiac Na channels lose their function? 1 - Numerical studies of the vulnerable period in tissue expressing mutant channels Cardiovasc Res, January 1, 2003; 57(1): 82 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Milberg, L. Eckardt, H.-J. Bruns, J. Biertz, S. Ramtin, N. Reinsch, D. Fleischer, P. Kirchhof, L. Fabritz, G. Breithardt, et al. Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 218 - 225. [Abstract] [Full Text] [PDF]
|
|